The streptococcal inhibitor of complement (SIC) protects Streptococcus pyogenes from bacteriocin-like inhibitory substance (BLIS) from Streptococcus salivarius: Research letter

FEMS Microbiology Letters

Volumn 298, Issue 1, 2009, Pages 67-73

  Minami, Masaaki ^a   Ohmori, Daisuke ^b   Tatsuno, Ichiro ^b   Isaka, Masanori ^b   Kawamura, Yoshiaki ^c   Ohta, Michio ^b   Hasegawa, Tadao ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Bacteriocin like inhibitory substance (BLIS); Streptococcal inhibitor of complement (SIC); Streptococcus pyogenes; Streptococcus salivarius

Indexed keywords

BACTERIOCIN; JCM 5707; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; GENE SEQUENCE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAIA GENE; SAIA2 GENE; SBO GENE; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SALIVARIUS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANTI-BACTERIAL AGENTS; ANTIBIOSIS; BACTERIAL PROTEINS; BACTERIOCINS; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE DELETION; HUMANS; STREPTOCOCCUS PYOGENES;

STREPTOCOCCUS; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SALIVARIUS;

EID: 68149122186     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2009.01696.x     Document Type: Article

References (24)

1. Akesson P, Sjoholm AG Bjorck L (1996) Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. J Biol Chem 271 : 1081 1088.
2. Aziz RK, Pabst MJ, Jeng A, Kansal R, Low DE Kotb M (2004) Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol Microbiol 51 : 123 134.
3. Brook I Gober AE (2000) In vitro bacterial interference in the nasopharynx of otitis media-prone and non-otitis media-prone children. Arch Otolaryngol 126 : 1011 1013.
4. Carlsson J, Grahnen G, Jonsson G Wikner S (1970) Early establishment of Streptococcus salivarius in the mouths of infants. J Dent Res 49 : 415 418.
5. Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13 : 470 511.
6. Dempster RP Tagg JR (1982) The production of bacteriocin-like substances by the oral bacterium Streptococcus salivarius. Arch Oral Biol 27 : 151 157.
7. Dierksen KP, Inglis M Tagg JR (2000) High pharyngeal carriage rates of Streptococcus pyogenes in Dunedin school children with a low incidence of rheumatic fever. New Zeal Med J 113 : 496 499.
8. Egesten A, Eliasson M, Johansson HM, Olin AI, Morgelin M Bjorck L (2007) The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes. J Infect Dis 195 : 684 693.
9. Fernie-King BA, Seilly DJ, Binks MJ, Sriprakash KS Lachmann PJ (2007) Streptococcal DRS (distantly related to SIC) and SIC inhibit antimicrobial peptides, components of mucosal innate immunity: a comparison of their activities. Microbes Infect 9 : 300 307.
10. Frick IM, Akesson P, Rasmussen M, Schmidtchen A Bjorck L (2003) SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J Biol Chem 278 : 16561 16566.
11. Hoe NP, Ireland RM, DeLeo FR, Gowen BB, Dorward DW Musser JM (2002) Insight into the molecular basis of pathogen abundance: group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into human cells. P Natl Acad Sci USA 99 : 7646 7651.
12. Hyink O, Wescombe PA, Upton M, Ragland N, Burton JP Tagg JR (2007) Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12. Appl Environ Microb 73 : 1107 1113.
13. Jack RW, Tagg JR Ray B (1995) Bacteriocins of gram-positive bacteria. Microbiol Rev 59 : 171 200.
14. Lukomski S, Hoe NP, Abdi I, Rurangirwa J, Kordari P Musser JM (2000) Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization. Infect Immun 68 : 535 542.
15. Nakamura T, Hasegawa T, Torii K, Hasegawa Y, Shimokata K Ohta M (2004) Two-dimensional gel electrophoresis analysis of the abundance of virulent exoproteins of group A Streptococcus caused by environmental changes. Arch Microbiol 181 : 74 81.
16. Podbielski A, Spellerberg B, Woischnik M, Pohl B Lutticken R (1996) Novel series of plasmid vectors for gene inactivation and expression analysis in group A streptococci (GAS). Gene 177 : 137 141.
17. Ross KF, Ronson CW Tagg JR (1993) Isolation and characterization of the Lantibiotic Salivaricin A and its structural gene salA from Streptococcus salivarius 20P3. Appl Environ Microb 59 : 2014 2021.
18. Sanders CC Sanders WE Jr. (1982) Enocin: an antibiotic produced by Streptococcus salivarius that may contribute to protection against infections due to group A streptococci. J Infect Dis 146 : 683 690.
19. Sawai J, Hasegawa T, Kamimura T, Okamoto A, Ohmori D Ohta M (2007) Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes. Antimicrob Agents Ch 51 : 461 467.
20. Tagg JR Bannister LV (1979) 'Fingerprinting' beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. J Med Microbiol 12 : 397 411.
21. Tanaka M, Hasegawa T, Okamoto A, Torii K Ohta M (2005) Effect of antibiotics on group A Streptococcus exoprotein production analyzed by two-dimensional gel electrophoresis. Antimicrob Agents Ch 49 : 88 96.
22. Tano K, Olofsson C, Grahn-Håkansson E Holm SE (1999) In vitro inhibition of S. pneumoniae, nontypable H. influenzae and M. catharralis by alpha-hemolytic streptococci from healthy children. Int J Pediatr Otorhi 47 : 49 56.
23. Upton M, Tagg JR, Wescombe P Jenkinson HF (2001) Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by salA and salA1 lantibiotic peptides. J Bacteriol 183 : 3931 3938.
24. Walls T, Power D Tagg JR (2003) Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media? J Med Microbiol 52 : 829 833.